iTeos Therapeutics SA
E_DEPRECATED Error in file »functions_general.php« at line 326: Function utf8_encode() is deprecated
E_DEPRECATED Error in file »functions_general.php« at line 326: Function utf8_encode() is deprecated
E_DEPRECATED Error in file »functions_general.php« at line 186: Function utf8_encode() is deprecated
E_DEPRECATED Error in file »functions_general.php« at line 186: Function utf8_encode() is deprecated
Category
iTeos is focused on expanding the benefits of immunotherapy for cancer patients by developing a proprietary pipeline targeting A2A, immune checkpoints and non-immunogenic (“cold”) tumors. It has licensed its IDO1 program, now in Phase 1 development, to Pfizer. iTeos’ competitive edge is in the combination of expertise in drug discovery and translational tumor immunology. The company uses a unique platform to identify rational combinations of immunotherapies and novel targets. Based in Gosselies, Belgium, iTeos is a spin-off from the Ludwig Cancer Research (LICR) and de Duve Institute (UCL). The company is supported in part by the Walloon Region of Belgium and the FEDER (European Fund for Economic and Regional Development).
Keywords:
0 results